Observational studyMedicine2020

Identification of MTHFD2 as a novel prognosis biomarker in esophageal carcinoma patients based on transcriptomic data and methylation profiling.

Jianlin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.